Sign in
4

Changes in Ownership

Citius Pharmaceuticals, Inc. Filed Acc 0001213900-21-010318

Options or other derivatives

  • Director acquired 25,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Holuka Eugene Myron Director 2021-02-16 Grant or award · Options to Purchase Common Stock +25,000 25,000 D: show line 1 in the form
Loading xslF345X03/ownership.xml…